January 2020 in “Journal of Cosmetics, Dermatological Sciences and Applications” TrichoxidilTM could be a promising new treatment for hair loss.
February 2025 in “Brazilian Journal of Hair Health” A personalized combination treatment can effectively promote hair growth and stabilize hair loss in women with androgenetic alopecia.
February 2025 in “Brazilian Journal of Hair Health” Personalized multimodal treatment significantly improved hair growth and scalp coverage in androgenetic alopecia without side effects.
38 citations
,
October 2011 in “Analytical biochemistry” Hair proteins have weak spots in their α-helical segments.
1 citations
,
February 2002 in “Oncology Times” Intravenous arsenic trioxide was shown to be a safe and effective treatment for relapsed acute promyelocytic leukemia (APL), achieving a complete remission rate of 87% in a study involving 52 patients. The treatment consisted of induction and consolidation phases, with manageable side effects such as APL differentiation syndrome and hyperleukocytosis. The study reported a two-year overall survival rate of 56% and a relapse-free survival rate of 49%. Additionally, arsenic trioxide demonstrated potential in treating other hematologic malignancies, with promising responses in patients with non-Hodgkin's lymphoma and multiple myeloma. The combination of arsenic trioxide with ascorbic acid was suggested to enhance its efficacy by overcoming drug resistance mechanisms in multiple myeloma cells.